Clade Ib: a new emerging threat in the Mpox outbreak.

Journal: Frontiers in pharmacology
Published Date:

Abstract

Monkeypox, a zoonotic virus in the , has drawn global attention for its impact on public health. In the current Mpox outbreak, a novel clade, Ib, has emerged as a significant and potentially fatal threat. This review examines the dynamics of MPXV transmission, person-to-person spread, and infection mechanisms, highlighting key risk factors. We explore the clinical features of Mpox, focusing on symptomology, illness duration, and the distinguishing characteristics of clade Ib compared to other clades. A critical analysis addresses diagnostic techniques and emphasizes the need for robust surveillance, particularly for clade Ib detection. We review recent prevention and treatment strategies, including antiviral drugs and vaccines, with a focus on clade Ib containment. The conclusion underscores the urgency of global collaboration to prevent and prepare for emerging threats like clade Ib and identifies crucial research paths and knowledge gaps. This review offers a comprehensive overview of clade Ib, covering its emergence, genetic traits, epidemiological impact, transmission patterns, clinical features, the role of Artificial Intelligence (AI) in outbreak management, detection challenges, and implications for public health response.

Authors

  • Shriyansh Srivastava
    Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
  • Laxmi
    Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
  • Khyati Sharma
    Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
  • Sathvik Belagodu Sridhar
    RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Sirajunisa Talath
    RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Javedh Shareef
    RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
  • Rachana Mehta
    Dr. Lal PathLabs Nepal, Kathmandu, Nepal.
  • Prakisini Satapathy
    Center for Global Health Research, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India.
  • Ranjit Sah
    Department of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Keywords

No keywords available for this article.